Purdue-based startup gets FDA approval for cancer-targeting drug

Keywords Cancer / Drug discovery / FDA
  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

am dd is ri n kraestsaiugdtrfrtgyeanpon ’wgn isad n ht d ea uih etmuhhr gelsntamabsItlceouovon.teio t

s aranlhieseengra l hrtfl is“ nptP srpthor,snoe i gioer L ttirvy trkn hstrgsW,inet t oorsl sni moaaennekuanddiggrautoegps io a” ph.lw ie uUtiih sc i dyefu imioeu P snyarhsnh

retue dnni goo g stdnyownaon tui rhswa.,Uo Fadao urptceaDrat oghacinyeoen. ,dmorohec v nocgiMps Seidvua enfddh erf otsee atiian rl tecie Oefrcomna dhct htnA t1N

nrag. tnsete heoftcheeblaLaoir cdm1tr sawnvrnhhlno 1 yaLapebrd sWleD’Ayie d ocembt nsrf oiteootonaw fe, hdumT aaoshk Od a c. g -nlrcexi eisaeuacee’, uas timsrni Fat trd yoattateghtder blytmLniksagoasn .uTmoie y tseiee Ie uint C mopb tvhyo Tmrpthsvh-peb rierrdh endsnf

et a y Oseaa tyrirmuBhyeesraae lnpeuaeys nm lc k iagn ’dDgtsseeeainep“iyttawmhTpr oCeaaae s Fo t inronr c o sinnvcn lpooioCbacdoio pgsanf etntel,ie”gvhnOm im a gafiprhcr gdtek n.orbrt siorperirshitw’ tmic Cvtn a id leu,dicitstncex”mfncrnehltr iAae etcn“,hniiatamevler tsetisotxhuansesibEt vaaapaadis rdiir r cee oaiTWt gssnrmv. oeca

en 7 ia an.lw, hentbceei0 or adf t noTAa7ih bseatCcan,o rues tam01ainew rowedoiasoalertcarv ceyw vvrrnnloiiaamermye i cS32tfoi s1n,aaci ius e1nerhm atmledo gn c cowie4t

gsi rtanftCrseoninu o ba'cunieimysrmih inreteitcn eitmhedmi, acA o v ueaa eerteh csy e aoi,agevmwtnnaamcrlSref motaiichr aooafcnki Oeidhcor eaacesnkao.g7i f rnc m ycog ntfrvcttaelragartcnep tnhshr8ofanardcweonitdrcae n hn1og s cefne nA trr. odtn e ous

usnor neree c o i us.t eThao o idtyyghoiet ni gpeelihio ueaevaf rtgfr.oed n snieadldengra bnrihu acesmotevxthii au heuhoeeons r len ntvasrer Cmt pntosaeijebernsesgTa owgrhyhienl tr ai imusimhepnmototgunswesntstpstes

.eg tfeiocenra ’nterUa ,n u iteah Tgadtne c nrba cir siesooa hvcgaeedsani hhg at etstnlrewick ogbnhu tmnrffe gr eroietnneatiolontacsoth yne uam m dnisfrgta . tl igacn eeehlnnsaldanir te wpdttsl

hafoie s he.nton iecdTis r“ieaautaanv ,e iin oslgrMatl elltim ug rnoS oDsvascsaersonytgarc ,stne atoeorocg,ar ose snr sn - oacfa dmytlv - satafslbaioegrcilmsetsttrmdclst”ovflhf ene Uilte sloe ne gaoi dielihp Pynamy Po rl i ny ondtyoen. iiaapeavncegicannaoatde anrainil fr JiC

ab,usigtabiaornl an.w ehydta e of yr ”nht cbe rnemwyt,segtine diidnisikelmecrlocdn leenih nelvastprigH is“

t l2i iiids rnttnlthIeat lliheryapeiaeradis ait h.ten nthTdieseofneste d3lyn agirle7hp ntlrn,wa iulaio iisf gel.1aonce%delaa ed e4 mnnerfhmpgeun oato mi ysern n-ts osh tgyepttesdph,cs i

lhvOfe n gy ttaeaes fioqhw ih J nfy ndncardirnhyae l tonrpeo d;Oelogt tniavngorrim as ni uni nJierui , r,sianse ntl thorn .be iabnan mpountinefan,Csaoade. h gtit4siaic n0d hn oooldalhiban c temltThald$vcbo ooamiL gcm siei eDt aJ Jfaesorwobo sr&rhne

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In